Use of ReX to dispense and monitor solid oral medication therapy.
Sponsors
Dosentrx Ltd.
Conditions
Any Solid Oral Medication
Unknown Phase
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
RecruitingNCT06335758
Start: 2024-01-15End: 2026-01-31Target: 1000Updated: 2024-03-28
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
RecruitingNCT06344416
Start: 2024-03-30End: 2026-01-30Target: 200Updated: 2025-03-12